These results suggested that regulation of the expression of MMP-12 and TGF-β1, particularly in the distribution in the airways and lung parenchyma, may be a strategy for the early treatment of chronic obstructive pulmonary disease. The gene discussed is TGFB1; the disease is chronic obstructive pulmonary disease.